Vanguard National Trust
GILD icon

Vanguard National Trust’s Gilead Sciences GILD Stock Holding History

Vanguard National Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Sell
2,337
-65
-3% -$8.56K 0.02% 231
2026
Q1 		$335K Buy
+2,402
New +$336K 0.02% 206

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard National Trust's GILD Position: Q2 2026 in Review

Vanguard National Trust reduced its Gilead Sciences (GILD) stake by 2.7% in Q2 2026, selling an estimated $8.56K and leaving 2,337 shares worth $295K. The position accounts for 0.02% of the portfolio, ranked #231.

Vanguard National Trust first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $335K in Q1 2026. 2,251 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Vanguard National Trust held 2,337 shares of Gilead Sciences worth $295K as of Q2 2026.
  • Vanguard National Trust sold 65 Gilead Sciences shares in Q2 2026, an estimated $8.56K.
  • Gilead Sciences made up 0.02% of Vanguard National Trust's portfolio in Q2 2026, its #231 holding.
  • Vanguard National Trust first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Vanguard National Trust's Gilead Sciences position peaked at $335K in Q1 2026.
  • 2,251 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.